CRISPR-Cas in Streptococcus pyogenes

Le Rhun, Anaïs; Escalera-Maurer, Andrés; Bratovič, Majda; Charpentier, Emmanuelle

doi:10.1080/15476286.2019.1582974

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_3317506_3

DetailsSummary

Released

Journal Article

CRISPR-Cas in Streptococcus pyogenes

MPS-Authors

Le Rhun, Anaïs
Max Planck Unit for the Science of Pathogens, Max Planck Society;

Charpentier, Emmanuelle
Max Planck Unit for the Science of Pathogens, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Le Rhun, A., Escalera-Maurer, A., Bratovič, M., & Charpentier, E. (2019). CRISPR-Cas in Streptococcus pyogenes. RNA biology, 16(4), 380-389. doi:10.1080/15476286.2019.1582974.

Cite as: https://hdl.handle.net/21.11116/0000-0008-744B-2

Abstract

The discovery and characterization of the prokaryotic CRISPR-Cas immune system has led to a revolution in genome editing and engineering technologies. Despite the fact that most applications emerged after the discovery of the type II-A CRISPR-Cas9 system of Streptococcus pyogenes, its biological importance in this organism has received little attention. Here, we provide a comprehensive overview of the current knowledge about CRISPR-Cas systems from S. pyogenes. We discuss how the interplay between CRISPR-mediated immunity and horizontal gene transfer might have modeled the evolution of this pathogen. We review the current literature about the CRISPR-Cas systems present in S. pyogenes (types I-C and II-A), and describe their distinctive biochemical and functional features. Finally, we summarize the main biotechnological applications that have arisen from the discovery of the CRISPR-Cas9 system in S. pyogenes.